IPS
NGNE icon

Investors Portfolio Services’s Neurogene NGNE Stock Holding History

Investors Portfolio Services’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472 Hold
15
– – ﹤0.01% 519
2026
Q1 		$477 Buy
+15
New +$291 ﹤0.01% 514

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Investors Portfolio Services's NGNE Position: Q2 2026 in Review

Investors Portfolio Services held its Neurogene (NGNE) position steady in Q2 2026 at 15 shares worth $472. The position accounts for ﹤0.01% of the portfolio, ranked #519.

Investors Portfolio Services first reported a position in NGNE in Q1 2026 and has held it in 2 quarters since. The position peaked at $477 in Q1 2026. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Investors Portfolio Services held 15 shares of Neurogene worth $472 as of Q2 2026.
  • Investors Portfolio Services left its Neurogene share count unchanged in Q2 2026.
  • Neurogene made up ﹤0.01% of Investors Portfolio Services's portfolio in Q2 2026, its #519 holding.
  • Investors Portfolio Services first reported a position in Neurogene in Q1 2026 and has held it in 2 quarters since.
  • Investors Portfolio Services's Neurogene position peaked at $477 in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Investors Portfolio Services's 13F filing for Q2 2026, filed 14 Aug 2026.